2021
DOI: 10.1080/20742835.2021.1962084
|View full text |Cite
|
Sign up to set email alerts
|

A retrospective study of the epidemiology and histological subtypes of ovarian epithelial neoplasms at Charlotte Maxeke Johannesburg Academic Hospital

Abstract: Background: Epithelial ovarian neoplasms constitute the majority of ovarian tumours and are the most common malignant ovarian neoplasm. They are the eighth leading cause of cancer deaths worldwide. This study evaluated the epidemiology and histological subtypes of epithelial ovarian neoplasms at a single institution. Methods: This retrospective, quantitative analysis evaluated 123 epithelial ovarian neoplasms between 2013 and 2017 and classified them according to age, biological behaviour and histological subt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 48 publications
1
1
0
Order By: Relevance
“…Almost half of the ovarian cancer patients in this study had an early-stage disease at the time of diagnosis. Consistent with previous studies [ 20 , 21 , 22 ], we found that most patients with early-stage ovarian cancer were classified as EOC (87.88%). However, the most common histology type in our cohort was the mucinous subtype (58.62%).…”
Section: Discussionsupporting
confidence: 92%
“…Almost half of the ovarian cancer patients in this study had an early-stage disease at the time of diagnosis. Consistent with previous studies [ 20 , 21 , 22 ], we found that most patients with early-stage ovarian cancer were classified as EOC (87.88%). However, the most common histology type in our cohort was the mucinous subtype (58.62%).…”
Section: Discussionsupporting
confidence: 92%
“…Most of the study revealed the different age distribution of gynecological cancers. 1,7,8 In this study, Majority of cervical cancer patients diagnosed between 35 years and 64 years. At NICRH, cervical cancer peaked at 50 years.…”
Section: Resultsmentioning
confidence: 99%